EMIS Group plc (AIM: EMIS.L), the UK leader in connected healthcare software and services, today announces a trading update for the six months ended 30 June 2018.
Overview
Trading for the half year has been in line with the Board’s expectations with revenue ahead of the comparative period as the Group continued to benefit from strong market shares, high levels of recurring revenue and good visibility in its order books and pipelines. The Board’s expectations for the full year remain unchanged.
Divisional review
In Primary, Community & Acute Care, the Group’s leading primary care market share has been maintained, while constructive discussions with NHS Digital continue with progress made in resolving the service level issues announced in January. The Group advanced again in Community with further contract wins, and the Acute business saw an improved performance.
The roll out of ProScript Connect, the Group’s next generation pharmacy dispensary management product in Community Pharmacy, has continued to plan, with the business moving forward positively.
The improvement in trading in Specialist & Care in the second half of 2017 was maintained during the period with a strong focus on operational delivery.
Patient continues to make good progress in building the first UK marketplace for healthcare. A major step in this project was the launch of an upgraded Patient Access app in May. In parallel, patient.info continues to develop its audience with increased focus on advertising sales.
Financial position
The Group’s net cash at 30 June 2018 was £32.3m (31 December 2017: £14.0m), benefiting from the usual seasonal first half inflow.
Notice of half year results
The Group intends to announce its results for the half year ended 30 June 2018 on 31 August 2018.
Andy Thorburn, CEO of EMIS Group, said: “EMIS Group has continued to trade in line with our expectations, while at the same time we have delivered good progress on the key projects set out in March and on developing our detailed plans for growth. The Board therefore remains confident in the outlook for the business.”
emis